Skip to content

Clinical trials

Myeloproliferative Disorders trials in Poland

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Myeloproliferative Disorders Country / region: Poland Clear all

20 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20111
20121
20131
20143
20152
20191
20203
20217
20221

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed11
Active, not recruiting4
Terminated3
Recruiting2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Incyte Corporation4
AOP Orphan Pharmaceuticals AG3
Celgene2
Novartis Pharmaceuticals2
Ariad Pharmaceuticals1
Cogent Biosciences, Inc.1
Constellation Pharmaceuticals1
FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS1
Geron Corporation1
Italfarmaco1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Myeloproliferative Disorders20
Primary Myelofibrosis10
Hematologic Diseases7
Bone Marrow Diseases6
Leukemia4
Neoplasms4
Polycythemia Vera4
Leukemia, Myelogenous, Chronic, BCR-ABL Positive3
Leukemia, Myeloid3
Leukemia, Myeloid, Acute3

Trials

Showing 26 to 20 of 20. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.